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Aims Although studies of the accuracy of heart failure (HF) classification scoring systems are available, few have examined
their performance when restricted to self-reported items.
Methods
and results
We evaluated the association between a simplified version of the Gothenburg score, a validated HF score comprised
of cardiac and pulmonary signs and symptoms and medication use, and incident HF hospitalizations in 15 430 Ather-
osclerosis Risk in Communities (ARIC) Study participants. Gothenburg scores (range: 0–3) were constructed using
self-reported items obtained at study baseline (1987–89). Incident HF hospitalization over 14.7 years of follow-up
was defined as the first identified hospitalization with an ICD-9 discharge code of 428 (n ¼ 1668). Self-reported
Gothenburg scores demonstrated very high agreement with the original metric comprised of self-reported and clini-
cal measures and were directly associated with incident HF hospitalizations: [score ¼ 1: hazard rate ratio
(HRR) ¼ 1.23 (1.07–1.42); score ¼ 2: HRR ¼ 2.17 (1.92–2.43); score ¼ 3: HRR ¼ 3.98 (3.37–4.70)].
Conclusion In a population-based cohort, self-reported Gothenburg criteria items were associated with hospitalized HF over a
prolonged follow-up time. The association was also consistent across groups defined by sex and race, suggesting that
this simple score deserves further study as a screening tool for the identification of individuals at high risk of HF in
resource-limited settings.
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Introduction
Heart failure (HF) is a common, costly, disabling, and often fatal dis-
order that affects approximately 14 million Europeans1 and 5.7
million Americans.2 Although treatment can reduce considerable
morbidity and mortality attributed to HF,3,4 approximately half of
those with HF die within 5 years after diagnosis.5,6 The changing
demography of the world’s population, including recent estimates
suggesting that 2 billion persons will be aged 60 or greater in
2050, further underscore the worldwide public health burden
posed by HF.7
The need for accurate and standardized HF classification criteria
operable for therapeutic trials and epidemiologic studies prompted
the development of several HF scoring systems including Framing-
ham,8 Gothenburg,9,10 NHANES-I,11 and Boston.12 All scores
share the same basic format of incorporating HF signs, symptoms,
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and clinical indices (to which various weights may be applied),
although the presence of rales is the only criterion included in
all scores. Three of the questionnaires, Framingham, Gothenburg,
and NHANES-I, were designed for epidemiologic studies; the
others were developed for drug trials.13
Although studies have contrasted the accuracy of HF scoring
systems for HF classification,13 few have examined the perform-
ance of parsimonious scoring systems restricted to items obtained
through self report. In particular, criteria that are simple to admin-
ister may facilitate screening of those at risk of future HF hospital-
ization, a salient question since HF consumes 1–2% of healthcare
resources in developed countries.14 Thus, we evaluated the associ-
ation between Gothenburg scores based on self-reported items
and incident HF hospitalizations in the cohort of the Atherosclero-
sis Risk in Communities (ARIC) Study.
Methods
Study
The ARIC Study includes an ongoing population-based cohort of
15 792 Caucasian and African American males and females aged 45–
64 years at study baseline from four US communities in Maryland, Min-
nesota, Mississippi, and North Carolina. Participants were recruited in
1987–89 to examine cardiovascular and pulmonary disease, patterns
of medical care, and disease variation over time.15 Standardized phys-
ical examinations and interviewer-administered questionnaires were
conducted at baseline, and at three follow-up examinations that
occurred at 3-year intervals. Participant follow-up through annual tele-
phone interviews, review of hospitalization records, and vital status is
ongoing. The investigation conforms with the principles outlined in the
Declaration of Helsinki, the Institutional Review Board at each partici-
pating institution approved the ARIC Study and all participants pro-
vided informed consent before each examination.
All cardiovascular risk factors were assessed at study baseline. Left
ventricular hypertrophy (LVH) was measured by electrocardiogram
(ECG) using Cornell criteria.16 Prevalent diabetes (defined as fasting
plasma glucose 6.93 mmol/L, non-fasting glucose 11.0 mmol/L, or
self-reported use of diabetes medications or physician diagnosis of dia-
betes), hypertension (defined as systolic blood pressure 140 mmHg
or diastolic blood pressure 90 mmHg or self-reported use of medi-
cations for blood pressure control), and obesity [body mass index
(BMI) 30 kg/m2] were examined as modifiers of the relationship
between self-reported Gothenburg score at baseline and incident hos-
pitalized HF.
Gothenburg score
The Gothenburg score was introduced in 1987 as a HF screening
tool.9,10 The score is derived from cardiac signs and symptoms, pul-
monary signs and symptoms, and therapies for HF, and used to classify
patients into four groups with increasing likelihood of having HF
(Table 1). The criteria were validated in several studies and shown
to have a sensitivity of 83.5 and a specificity of 80.9 for classifying
HF in a random sample of health care recipients.13
Scores for the full Gothenburg criterion were assigned in this study
at baseline from standardized physical examinations and interviewer-
administered questionnaires as part of the ARIC protocol. Rhonchi
and rales were detected during physical examination by a nurse or
physician’s assistant and atrial fibrillation was ascertained during
central processing of digitized ECG records. All other signs and
symptoms, as well as prevalent coronary heart disease (CHD) or
angina, were reported by participants on interviewer-administered
questionnaires (Table 1). Participants were assigned a Gothenburg
score ¼ 0 if they had no signs or symptoms in all categories. A
Gothenburg score ¼ 1 was assigned to participants positive for only
cardiac signs and symptoms, a score ¼ 2 corresponds to positive
responses in the cardiac and symptoms category and either the pul-
monary signs and symptoms or therapy categories. Those with
score ¼ 3 were positive in all three categories (cardiac, pulmonary,
and therapy). Of note, each score component is represented by a
binary indicator that does not discriminate between one or multiple
positive responses for a given category. Self-reported Gothenburg
scores were assigned based only on the self-reported signs and symp-
toms (i.e. excluding rales, rhonchi, and atrial fibrillation on ECG)
without modification of the rest of the scoring. Hereafter, the full
Gothenburg score (including both physical signs and self-reported
items) is referred to as the ‘original’ and the reduced set of self-
reported items is referred to as ’self-reported’.
Outcome
Events were ascertained through yearly interviews of cohort members
during which all hospitalizations were reported as well as active sur-
veillance of local hospital discharge lists to identify cohort hospitaliz-
ations with cardiovascular disease diagnoses. Incident HF
hospitalizations were defined as a participant’s first recorded hospital-
ization with an International Classification of Diseases, Ninth Revision
(ICD-9) discharge code ¼ 428 in any position. Heart failure hospitaliz-
ations were not validated for the presence of acute, decompensated
HF by a review of the pertinent hospital records. Information on hos-
pitalizations preceding the ARIC baseline examinations was unavailable.
Follow-up time was calculated as time from study enrolment and com-
pletion of the Gothenburg questionnaire to either incident HF hospi-
talization, loss to follow-up, death, or 31 December 2004, the last date
of complete hospitalization data.
Statistical analysis
We excluded a total of 362 participants from the analysis: 83 partici-
pants with prevalent HF, defined as a positive response to the question
‘were any of the medications you took during the past two weeks for
heart failure’, 48 participants who reported a race other than African
American or Caucasian, and 231 participants who had insufficient
data at baseline to assign a Gothenburg score. Race- and sex-specific
age-standardized incidence rates (IRs) of hospitalized HF were calcu-
lated using age in 5-year categories. Hazard rate ratios (HRRs) were
estimated using Cox regression. The assumption of proportional
hazards was confirmed by visual examination of survival plots. All stat-
istical modelling was performed using SAS v9.1.3 (Cary, NC, USA).
Results
Agreement between the original and self-reported Gothenburg
scores at baseline was very high in the combined population
(Table 2) and across subpopulations defined by sex and race
(data not shown). Prevalence estimates for the clinically measured
signs and symptoms excluded from the self-reported Gothenburg
score were generally low: atrial fibrillation on ECG and rales were
identified in 31 (0.2%) and 105 (0.7%) participants, respectively
(Table 3). Although rhonchi was more frequent (3.9%), its exclu-
sion did not affect score assignment appreciably, as it frequently
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co-occurred with other pulmonary signs and symptoms (55.7%) or
occurred in the absence of cardiac signs and symptoms (27.0%).
There were 1668 incident HF hospitalizations over a mean
follow-up time of 14.7 years. Incident HF hospitalizations occurred
on average 9.6 years (Figure 1) after the baseline examination
(range: 0.03–17.9 years). Almost half (44%) of ARIC participants
who survived their first HF hospitalization were re-admitted or
died within 6 months of discharge.
Participants with higher Gothenburg scores at baseline were
more likely to be African American, female, have educational
achievement of high school or less, to be current smokers, and
be slightly older (Table 3). Mean BMI, the prevalence of diabetes,
and the presence of LVH on ECG all showed a monotonic increase
across increasing Gothenburg scores. The majority of participants
with a Gothenburg score ¼ 3 were hypertensive at baseline
(78.5%).
Age-adjusted IRs of hospitalized HF were directly associated
with self-reported Gothenburg scores (Table 4). The association
also varied by sex; estimated IRs were highest for males, but
were comparable across race after stratification by sex. Self-
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Prevalent CHD Self-report Positive response to the question: Has a doctor ever said you had a heart attack?
Angina Self-report
† Positive response to ‘Have you ever had any pain or discomfort in your chest?’ and
† Positive response to either ‘Do you get it when you walk uphill or hurry?’ or ‘Do you get it when
you walk at an ordinary pace on the level?’ and
† Response of ‘Stop or slow down’ when asked ‘What do you do if you get it while you are walking?’
and
† Response of ‘Relieved’ when asked ‘If you stand still, what happens?’ and
† Response of ‘10 min or less’ when asked ‘How soon?’
Oedema Self-report Positive responses to both of the following questions:
† ‘Have you ever had swelling of your feet or ankles (excluding during pregnancy)?’
† ‘Did it tend to come on during the day and go down overnight?’
Nocturnal
dyspnoea
Self-report Positive response to the question: ‘Have you ever been awakened at night by trouble breathing?’
Rales Physical exam N/A




Self-report Positive response to the question: ‘Have you ever had chronic bronchitis?’
Chronic asthma Self-report Positive response to the question: ‘Have you ever had chronic asthma?’
Cough, phlegm,
or wheezing
Self-report Positive response to any of the following questions:
† ‘Do you usually have a cough?’
† ‘Do you usually bring up phlegm from your chest?’
† ‘Does your chest ever sound wheezy or whistling apart from colds?’
Rhonchi Physical exam N/A
Therapy
Digitalis Self-report Medication codes (312xxx)
Diuretics Self-report Medication codes (37xxxx)
ARIC, Atherosclerosis Risk in Communities Study; CHD, coronary heart disease; ECG, electrocardiogram.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Table 2 Agreement between original and self-reported





0 1 2 3 Total
0 9123 0 0 0 9123
1 24 2647 0 0 2671
2 41 62 2768 0 2871
3 8 0 25 638 671
Total 9196 2709 2793 638 15 336
ARIC, Atherosclerosis Risk in Communities Study.
aScore: 0, no signs or symptoms; 1, cardiac signs and symptoms only; 2, cardiac
signs and symptoms and either pulmonary signs and symptoms or therapy; 3,
cardiac and pulmonary signs and symptoms and therapy.
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Table 3 Baseline characteristics of ARIC Study participants (N 5 15 430) by Gothenburg score, 1987–1989a
Baseline characteristics Gothenburg score
0 1 2 3
(N 5 9268; 60%) (N 5 2726; 18%) (N 5 2798; 18%) (N 5 638; 4%)
Age (years) 54.0 (5.7) 53.9 (5.7) 54.6 (5.8) 55.5 (5.6)
African American 24.8 27.8 29.6 37.8
Female 46.7 69.1 67.4 72.4
Current smoker 25.7 19.5 32.4 31.0
Current alcohol consumer 60.5 49.9 49.4 41.6
 High school education 52.5 56.8 64.1 68.6
BMI (kg/m2) 26.9 (4.6) 28.2 (5.7) 29.1 (6.3) 31.1 (6.8)
SBP (mm Hg) 120.8 (18.4) 120.4 (19.2) 122.8 (19.4) 125.1 (19.8)
DBP (mm Hg) 73.8 (11.1) 73.1 (11.5) 73.5 (11.4) 74.9 (11.8)
Hypertension 30.5 27.2 46.1 78.5
Diabetes 9.3 10.2 17.7 27.2
LVH present on ECG 1.7 2.4 3.0 4.7
Atrial fibrillation on ECG 0.18 0.03 0.25 0.94
Rales 0.61 0.37 1.3 0.63
Rhonchi 3.4 5.4 6.1 6.1
ARIC, Atherosclerosis Risk in Communities Study; BMI, body mass index; CHD, coronary heart disease; DBP, diastolic blood pressure; ECG, electrocardiogram; LVH, left
ventricular hypertrophy; SBP, systolic blood pressure.
aData are percentages for dichotomous characteristics and means (standard deviation) for continuous variables.
Figure 1 Kaplan–Meier curves of incident heart failure hospitalization by self-reported Gothenburg score, stratified by gender and race.
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reported Gothenburg scores were also directly associated with
HRRs of incident hospitalized HF (Table 4). However, HRRs associ-
ated with self-reported Gothenburg score ¼ 3 were greatest for
Caucasian males and females, in contrast to IR estimates that
were highest among male participants, reflecting the higher esti-
mated IRs of HF observed among African American participants
with Gothenburg score ¼ 0.
When examining the components of the Gothenburg criteria,
the prevalence of HF therapy (digitalis and diuretic) at ARIC
Study baseline (18.5%; 2642 self-reported diuretic use, 117
reported digitalis use, and 92 reported diuretic and digitalis use)
was lower than the prevalence of cardiac (39.9%) and pulmonary
(30.4%) signs and symptoms. However, combinations of criteria
that included therapy were associated with the highest relative
rates of incident HF hospitalizations when all combinations of
the three criteria were evaluated in a multivariable model
(Table 5). As expected, estimated HRRs of incident HF hospitaliz-
ation were highest for populations with positive responses to all
three Gothenburg criteria.
Baseline hypertension status modified the relationship between
self-reported Gothenburg score and incident hospitalized HF (P ,
0.0001), unlike obesity and diabetes (Figure 2, numeric estimates
provided in Supplementary material online, Table S1). Hazard
rate ratio estimates adjusted for age, sex, and race were consist-
ently higher for participants who were normotensive at study base-
line. The largest discrepancies were seen among participants with
Gothenburg score ¼ 3 [HRR (95% CI) for hypertensive
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Table 4 Incidence rates per 1000 person-years and hazard rate ratios of heart failure hospitalization by self-reported
Gothenburg scores, race, and sex among 15 430 ARIC Study participants, 1987–2004
Score All participants Caucasians African Americans
Males (N 5 5316) Females (N 5 5989) Males (N 5 1558) Females (N 5 2567)
Incidence rate (95% CI)a
0 5.40 (5.01, 5.79) 5.82 (5.19, 6.44) 3.63 (3.09, 4.17) 7.87 (6.51, 9.23) 7.11 (5.85, 8.37)
1 6.73 (5.92, 7.53) 11.51 (9.38, 13.64) 3.1 (2.33, 3.87) 13.43 (8.59, 18.27) 8.46 (6.46, 10.46)
2 10.48 (9.42, 11.54) 15.47 (12.86, 18.07) 8.04 (6.63, 9.46) 17.98 (12.5, 23.46) 9.56 (7.36, 11.76)
3 20.99 (17.87, 24.1) 33.95 (22.92, 44.97) 16.63 (12.59, 20.68) 32.27 (16.44, 48.1) 18.67 (13.25, 24.08)
Hazard rate ratio (95% CI)b
0 1 1 1 1 1
1 1.23 (1.07, 1.42) 2.01 (1.62, 2.48) 0.86 (0.65, 1.15) 1.60 (1.06, 2.41) 1.18 (0.87, 1.59)
2 2.17 (1.92, 2.43) 2.99 (2.48, 3.61) 2.29 (1.85, 2.84) 2.66 (1.91, 3.70) 1.61 (1.24, 2.10)
3 3.98 (3.37, 4.70) 5.69 (4.19, 7.73) 4.96 (3.74, 6.59) 4.27 (2.57, 7.10) 2.71 (1.94, 3.77)
ARIC, Atherosclerosis Risk in Communities study; CI, confidence interval; HF, heart failure; IR, incidence rate.
aAge standardized and presented per 1000 person-years.
bAge adjusted.
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Table 5 Hazard rate ratios of incident heart failure
hospitalization by self-reported Gothenburg score





Person-years HRR (95% CI)a
None 385 94 191 1
One criterion
Cardiac 270 40 629 1.59 (1.36, 1.86)
Pulmonary 172 27 875 1.46 (1.22, 1.75)




274 25 419 2.63 (2.25, 3.07)
Cardiac and
therapy
195 13 843 3.06 (2.57, 3.65)
Pulmonary and
therapy





179 7914 5.16 (4.32, 6.18)
CI, confidence interval; HF, heart failure; HRR, hazard rate ratio.
aAdjusted for age, sex, and race.
Figure 2 Adjusted hazard rate ratios of incident heart failure
hospitalization by self-reported Gothenburg score, stratified by
baseline hypertensive status.
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participants: 2.81 (2.31, 3.42); normotensive participants: 8.27
(5.92, 11.54)].
Discussion
The burden of HF in economically developed countries has steadily
increased over the past decades,17,18 reflecting numerous factors
including the ageing populations19,20 and improved survival follow-
ing myocardial infarctions.21,22 Patients with HF also have signifi-
cantly greater functional limitations, in-home care needs, and
nursing home admissions when compared with those with other
cardiovascular diseases including CHD.23 Thus, identifying popu-
lations at long-term risk for future HF hospitalizations in outpati-
ent/primary care settings could target proactive care before the
syndrome and its associated disability worsen.
In this report, we evaluated the association between a simplified
Gothenburg score, previously validated as a HF screening criterion,
and incident hospitalized HF in a large, bi-racial US cohort. Specifi-
cally, we focused on the performance of the Gothenburg criteria
restricted to self-reported items and showed that simple measure-
ments reported by the study participants at baseline are associated
with HF hospitalization over long-term follow-up. Moreover, the
Gothenburg scores restricted to self-reported items demonstrated
high agreement with the original score.
Two prior reports examined combinations of patient character-
istics that can enable the identification of individuals at high risk of
HF. Kannel et al.24 identified a risk score to predict HF cases over
38 years of follow-up in the Framingham Heart Study and a recent
report estimated a risk score in the Health ABC study of elderly
individuals over a mean follow-up of 6.5 years.25 Briefly, Kannel
et al. included age, electrocardiographic LVH, cardiomegaly on
chest x-ray film, heart rate, systolic blood pressure, vital capacity,
diabetes mellitus, evidence of myocardial infarction, and valvular
disease or hypertension. The nine HF predictors Health ABC
investigators identified included prior CHD, systolic blood
pressure, cigarette smoking, heart rate, age, LVH, and serum crea-
tinine, albumin, and fasting glucose. Kannel et al. identified HF out-
comes identified through clinic examinations, hospital admissions,
and physician’s records according to the Framingham criteria8
and Health ABC investigators classified first hospital admissions
as incident HF based on criteria similar to those used in the Car-
diovascular Health Study.26
The contrast with the parsimony of the Gothenburg score is
readily apparent (Table 1), particularly considering the simple and
non-invasive nature of the characteristics included in the score
and its potential application as a screening tool in resource-limited
settings. Emphasizing this point, we note the high degree of con-
cordance between the original and self-reported scores. If repli-
cated in other populations, our results are relevant in the
context of several studies which suggested that HF misdiagnosis
by primary care physicians is common.27,28
However, we make no direct comparisons with the properties
of the HF prediction risk equations reported by the Framingham
Heart Study and the Heath ABC investigators. Our study
focused on the evaluation of an initial hospitalization with a HF dis-
charge code, not otherwise validated for HF. Instead of deriving
another HF risk prediction algorithm, we wish to highlight the
potential advantages of a simple score such as the Gothenburg cri-
terion constructed using self-reported items, as an initial assess-
ment that can serve to identify populations who may benefit
from clinical examination and/or measurements such as bio-
markers or echocardiography.
We note that of the short list of self-reported items considered,
therapies for HF (restricted to digitalis and diuretics) were associ-
ated with the greatest relative rate of incident HF hospitalizations
in the ARIC cohort. Some HF therapies commonly used at present
(e.g. beta-blockers and ACE-inhibitors) were not in wide use at the
time of ARIC’s baseline examination or when the Gothenburg
score was developed. Although few therapies are specific for HF
in their indications, their inclusion in an updated list of self-
reported items may be warranted. At this point, it is also unclear
whether the greater relative rates of disease observed in ARIC par-
ticipants who were normotensive at baseline reflect different path-
ways to the HF syndrome than in hypertensives, or a population in
which the Gothenburg score performs better. Replication of these
results is needed before interpretations are proposed.
We highlight several limitations of this study including the poten-
tial for inaccuracy associated with self-reported items included in
the construction of the Gothenburg scores. The literature examin-
ing the accuracy of self-reported items such as those used to con-
struct Gothenburg scores suggests moderate-to-high agreement
with physician diagnoses and medical records,29–31 with most
items being highly specific but with varying levels of sensitivity. Cri-
teria that are moderately sensitive, but highly specific would gener-
ally lead to underestimation of Gothenburg scores and an
attenuation of the association with incident hospitalized HF.
However, the design of the Gothenburg score may minimize this
concern, as each score component is represented by a binary indi-
cator that does not discriminate between one or multiple positive
responses for a given category.
We also point out that prevalent HF at baseline was identified,
for exclusion, only based on participant self-report of the use of
medication prescribed for HF. An examination of the timing of inci-
dent HF hospitalizations suggests that very few (,6%) HF hospital-
izations occurred within 2 years of the baseline examination.
Although we have no information on hospitalizations preceding
the baseline ARIC examination, excluding from the analyses all
events that occurred within 2 years of study enrolment did not
visibly alter our results (data not shown).
We also note that we relied on 428 discharge codes to identify HF
hospitalizations that were not validated for the presence of acute,
decompensated HF by a review of the pertinent hospital records.
Reports from the Women’s Health Initiative Clinical Trial and Obser-
vational Study suggest moderate to good agreement between an
ICD-9 428 hospital discharge codes and local adjudication; estimates
of the sensitivity and specificity of ICD-9 code 428 were 78.3 and
98.1%, respectively.32 Analyses of incident HF events in our popu-
lations based on at least two hospitalizations listing a 428 discharge
code in ARIC cohort participants (n ¼ 900 events) were fully con-
sistent with those presented herein (data not shown).
These limitations notwithstanding, our results suggest the
potential applicability of the parsimonious Gothenburg criterion
constructed using self-reported questionnaire items in population-
based studies. The high agreement between the self-reported and
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the original score, their comparable relative rate estimates, and the
consistency across groups defined by sex and race indicate that the
self-reported score could be applied as a screening tool in
resource-limited settings without compromising accuracy. Thus,
the potential impact of these results warrants their prompt replica-
tion in other populations.
Supplementary material
Supplementary material is available at European Journal of Heart
Failure online.
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